Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

5.71
+0.14002.51%
Pre-market: 5.50-0.2100-3.68%06:02 EDT
Volume:123.89K
Turnover:704.65K
Market Cap:286.79M
PE:-3.26
High:5.86
Open:5.61
Low:5.53
Close:5.57
Loading ...

Aura Biosciences Inc (AURA) Receives a Buy from Scotiabank

TIPRANKS
·
03 Apr

BRIEF-Aura Biosciences Announces Appointment Of Teresa Bitetti To Board Of Directors

Reuters
·
02 Apr

Aura Biosciences Expands Board with New Director Appointment

TIPRANKS
·
02 Apr

Aura Biosciences appoints Bitetti to board of directors

TIPRANKS
·
02 Apr

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

THOMSON REUTERS
·
02 Apr

Press Release: Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

Dow Jones
·
02 Apr

Evercore ISI Sticks to Its Buy Rating for Aura Biosciences Inc (AURA)

TIPRANKS
·
01 Apr

US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert

Benzinga
·
27 Mar

Aura Energy Limited (AURA) Gets a Buy from Petra Capital

TIPRANKS
·
27 Mar

Aura Biosciences Down Nearly 12%, on Track for Record Low Close -- Data Talk

Dow Jones
·
27 Mar

Aura Biosciences Stock (AURA) Continues to Slide Despite Promising Clinical Progress

TIPRANKS
·
26 Mar

Aura Biosciences Is Maintained at Market Outperform by Citizens Capital Markets

Dow Jones
·
26 Mar

Aura Biosciences Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
26 Mar

Scotiabank Sticks to Its Buy Rating for Aura Biosciences Inc (AURA)

TIPRANKS
·
25 Mar

Aura Biosciences FY24 EPS $(1.75) Up From $(1.93) YoY

Benzinga
·
25 Mar

BRIEF-Aura Biosciences FY Operating Income USD -96.116 Million

Reuters
·
25 Mar

Aura Biosciences Inc - Cash Position Expected to Support Operations Into 2H 2026

THOMSON REUTERS
·
25 Mar

Aura Biosciences FY Operating Income USD -96.116 Million

THOMSON REUTERS
·
25 Mar

Press Release: Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Dow Jones
·
25 Mar

Aura Biosciences Down Over 7%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

Dow Jones
·
25 Mar